Shots: Sanofi and Stanford Medicine collaborated to initiate three “deep-dive” research projects focusing on autoimmune diseases and inflammatory conditions The partners will organize a joint committee to fund three programs […]readmore
Tags : Autoimmune
Shots: BioMed and Merck & Co (MSD outside the United States and Canada) signs an agreement and extends their ongoing collaboration for six joint research projects at BioMed X Innovation […]readmore
Shots: Dragonfly to receive upfront, milestones and royalties on licensed therapies. AbbVie to get an exclusive option to license global intellectual property rights to develop and commercialize therapies developed during […]readmore
Shots: Aduro to receive $12M upfront, up to $620M milestones and royalties on sales from Lilly. Lilly to get rights for Aduro’s cGAS-STING pathway inhibitor program and will be responsible for all costs […]readmore
Shots: Genentech to acquire Jecure, in all stock transaction for the portfolio of preclinical NLRP3 inhibitors The acquisition is focus to develop therapies using Jecure’s NLRP3 inhibitors for the treatment […]readmore
Shots: The approval is based on non-inferiority data assessing Hyrimoz vs reference biologic in patients with rheumatoid arthritis, plaque psoriasis, Crohn’s disease, uveitis and ulcerative colitis The study demonstrated in […]readmore